2019, a year to remember


Looking back at 2019, one thing is certain – What a year!

Nano4 became closer to its goal, to launch innovative nanotechnology based molecular diagnostic.

2019 highlights:

  • Opening the industrial facility in Sintra, Portugal
  • Successfully concluded a follow-on funding round.
  • Team reached 6 members including production, quality control and R&D.
  • R&D lab was set up to enable further research
  • Nano4 Global was considered by Labiotech one of the “Top 15 companies you should know in Portugal”
  • Website launch and, a few months later, initiated LinkedIn and Twitter spread
  • In Q2, Nano4 Global reached a key milestone - ISO 9001:2015 and 13485:2016 certifications for the production of molecular diagnostics.
  • We concluded the industrial scale-up process of Nano4TB – disruptive nanodiagnostics for detection of M. tuberculosis.
  • Nano4 Global was recognized as a NOVA SPIN-OFF
  • During 2019, Nano4 Global participated in a series of events: European Molecular Diagnostic Congress; member of panel for the European Funding Programs from the European Innovation Council Presented at Innohealth, India - a one-stop platform in healthcare innovation; was present at Medica trade fair, in Germany; and participated in the Healthcare Business Summit in Portugal. At the WebSummit, Nano4 Global was panel member in the European Commission session.
  • In December, we closed the year celebrating our 4th Anniversary.

Thanks to all collaborators, investors, advisors, partners and friends that trust on us and believe on the success of Nano4!


News & Updates
  July  2021
NANO4 in partnership with CUF Hospitals and Clinics network initiates validation of diagnostics platform for Chronic Myeloid Leukaemia
  November  2019
NANO4 was recognized with the NOVA SPIN-OFF seal